Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (476)
Cancellation by sponsor (195)
Cancellation or suspension (77)
Prescription medicine registration (37)
Cancellation for failure to pay annual charge (17)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2024 (73)
2023 (102)
2022 (74)
2021 (76)
2020 (120)
2019 (22)
2018 (69)
2017 (106)
2016 (31)
2015 (36)
2014 (21)
2013 (9)
2012 (5)
2011 (6)
2010 (20)
2009 (5)
2008 (3)
2007 (6)
2006 (7)
2005 (2)
2004 (2)
2003 (4)
2002 (3)
2001 (4)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Results for "[search-keyword]"

Search

Sponsor content

811 result(s) found, displaying 721 to 730

MEDIHEALTH LORATADINE loratadine 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
GUARDIAN CHILDREN'S PARACETAMOL SUSPENSION FOR 6 TO 12 YEARS paracetamol 48 mg/mL oral liquid bottle Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
GUARDIAN HEARTBURN RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
GUARDIAN HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
GUARDIAN ANTIFUNGAL CREAM 1% clotrimazole 10mg/g tube Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
EcoVag Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
EcoVag Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
AMCAL IBUPROFEN PLUS CODEINE film-coated tablet blister pack (Cipla Australia Pty Ltd)

25 June 2015

Cancellation for failure to pay annual charge

Cancelled under Section 30(2)(f) of the Act
PHARMACY CARE IBUPROFEN PLUS CODEINE film-coated tablet blister pack (Cipla Australia Pty Ltd)

25 June 2015

Cancellation for failure to pay annual charge

Cancelled under Section 30(2)(f) of the Act
PHARMACY CARE SINUS PAIN RELIEF PE tablet blister pack (Cipla Australia Pty Ltd)

25 June 2015

Cancellation for failure to pay annual charge

Cancelled under Section 30(2)(f) of the Act

Pages

First page
Previous page
…
Page 69
Page 70
Page 71
Page 72
Current page 73
Page 74
Page 75
Page 76
Page 77
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.